82 related articles for article (PubMed ID: 15388795)
1. 17beta-estradiol activation of the c-Jun N-terminal kinase pathway leads to down-regulation of class II major histocompatibility complex expression.
Adamski J; Benveniste EN
Mol Endocrinol; 2005 Jan; 19(1):113-24. PubMed ID: 15388795
[TBL] [Abstract][Full Text] [Related]
2. 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter.
Adamski J; Ma Z; Nozell S; Benveniste EN
Mol Endocrinol; 2004 Aug; 18(8):1963-74. PubMed ID: 15143155
[TBL] [Abstract][Full Text] [Related]
3. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
[TBL] [Abstract][Full Text] [Related]
4. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.
Kitamura N; Yokoyama H; Yashiro T; Nakano N; Nishiyama M; Kanada S; Fukai T; Hara M; Ikeda S; Ogawa H; Okumura K; Nishiyama C
J Allergy Clin Immunol; 2012 Mar; 129(3):814-824.e6. PubMed ID: 22112519
[TBL] [Abstract][Full Text] [Related]
5. Thombospondin-1 disrupts estrogen-induced endothelial cell proliferation and migration and its expression is suppressed by estradiol.
Sengupta K; Banerjee S; Saxena NK; Banerjee SK
Mol Cancer Res; 2004 Mar; 2(3):150-8. PubMed ID: 15037654
[TBL] [Abstract][Full Text] [Related]
6. C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis.
Zeng C; Xu JN; Zhou Y; Yang HX; Zhou YF; Xue Q
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1404-14. PubMed ID: 26394174
[TBL] [Abstract][Full Text] [Related]
7. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
Choi YE; Yu HN; Yoon CH; Bae YS
Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
[TBL] [Abstract][Full Text] [Related]
8. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
[TBL] [Abstract][Full Text] [Related]
10. Involvement of ERK, p38 MAP kinase, and PKC in MHC class II-mediated signal transduction in a resting B cell line.
Kim J; Kim HR; Lee JC; Jang YS
Biochem Biophys Res Commun; 2002 Feb; 291(1):139-45. PubMed ID: 11829473
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway.
Wade CB; Robinson S; Shapiro RA; Dorsa DM
Endocrinology; 2001 Jun; 142(6):2336-42. PubMed ID: 11356680
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.
Li G; Harton JA; Zhu X; Ting JP
Mol Cell Biol; 2001 Jul; 21(14):4626-35. PubMed ID: 11416140
[TBL] [Abstract][Full Text] [Related]
14. c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.
Madeo A; Vinciguerra M; Lappano R; Galgani M; Gasperi-Campani A; Maggiolini M; Musti AM
Oncogene; 2010 Feb; 29(7):978-91. PubMed ID: 19935718
[TBL] [Abstract][Full Text] [Related]
15. Signal pathway of 17beta-estradiol-induced MUC5B expression in human airway epithelial cells.
Choi HJ; Chung YS; Kim HJ; Moon UY; Choi YH; Van Seuningen I; Baek SJ; Yoon HG; Yoon JH
Am J Respir Cell Mol Biol; 2009 Feb; 40(2):168-78. PubMed ID: 18688042
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
[TBL] [Abstract][Full Text] [Related]
17. Anti endothelial cell autoantibodies selectively activate SAPK/JNK signalling in Wegener's granulomatosis.
Holmén C; Elsheikh E; Christensson M; Liu J; Johansson AS; Qureshi AR; Jalkanen S; Sumitran-Holgersson S
J Am Soc Nephrol; 2007 Sep; 18(9):2497-508. PubMed ID: 17699811
[TBL] [Abstract][Full Text] [Related]
18. Synthetic estrogens-mediated activation of JNK intracellular signaling molecule.
Prifti S; Mall P; Strowitzki T; Rabe T
Gynecol Endocrinol; 2001 Apr; 15(2):135-41. PubMed ID: 11379010
[TBL] [Abstract][Full Text] [Related]
19. Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes.
Dos Santos EG; Dieudonne MN; Pecquery R; Le Moal V; Giudicelli Y; Lacasa D
Endocrinology; 2002 Mar; 143(3):930-40. PubMed ID: 11861515
[TBL] [Abstract][Full Text] [Related]
20. Pathologic expression of MHC class II is driven by mitogen-activated protein kinases.
Martins I; Deshayes F; Baton F; Forget A; Ciechomska I; Sylla K; Aoudjit F; Charron D; Al-Daccak R; Alcaide-Loridan C
Eur J Immunol; 2007 Mar; 37(3):788-97. PubMed ID: 17304627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
